Combined salmeterol and fluticasone for COPD.
Steffen
S
Thirstrup
Jens Peter
JP
Kampmann
D000420:Albuterol / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use*; D000730:Androstadienes / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D000068298:Fluticasone; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D015203:Reproducibility of Results; D000068299:Salmeterol Xinafoate
D000730:Androstadienes; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol